期刊
FUTURE ONCOLOGY
卷 6, 期 4, 页码 587-603出版社
FUTURE MEDICINE LTD
DOI: 10.2217/FON.10.15
关键词
cel signaling; cell survival; integrative cancer therapy; oncogene; tumor suppressor
类别
资金
- NIH [CA111891, AG026630, ES016888]
- Department of Defense [PC040569]
- NATIONAL CANCER INSTITUTE [R01CA111891] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R03ES016888] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE ON AGING [R03AG026630] Funding Source: NIH RePORTER
Carcinogenesis is the uncontrolled growth of cells gaining the potential to invade and disrupt vital tissue functions. This malignant process includes the occurrence of 'unwanted' gene mutations that induce the transformation of normal cells, for example, by overactivation of pro-oncogenic pathways and inactivation of tumor-suppressive or anti-oncogenic pathways. It is now recognized that the number of major signaling pathways that control oncogenesis is not unlimited; therefore, suppressing these pathways can conceivably lead to a cancer cure. However, the clinical application of cancer intervention has not matched up to scientific expectations. Increasing numbers of studies have revealed that many oncogenic-signaling elements show double faces, in which they can promote or suppress cancer pathogenesis depending on tissue type, cancer stage, gene dosage and their interaction with other players in carcinogenesis. This complexity of oncogenic signaling poses challenges to traditional cancer therapy and calls for considerable caution when designing an anticancer drug strategy. We propose future oncology interventions with the concept of integrative cancer therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据